Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms
- 12 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Human Genetics
- Vol. 126 (4), 559-565
- https://doi.org/10.1007/s00439-009-0704-z
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- COX2 and p53 risk-alleles coexist in COPDClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- The common germline Arg72Pro polymorphism of p53 and increased longevity in humansCell Cycle, 2008
- p53: more research and more questionsCell Death & Differentiation, 2006
- MDM2 is a Central Node in the p53 Pathway: 12 Years and CountingCurrent Cancer Drug Targets, 2005
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- Association testing by DNA pooling: An effective initial screenProceedings of the National Academy of Sciences of the United States of America, 2002
- Is p53 Polymorphism Maintained by Natural Selection?Human Heredity, 1994
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992